Bellerophon Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch BLPH and buy or sell other stocks, ETFs, and their options commission-free!

About BLPH

Bellerophon Therapeutics, Inc. is a clinical-stage therapeutics company, which focuses on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. The company engages in two programs including INOpulse and BCM. 

CEO
Fabian Tenenbaum
CEOFabian Tenenbaum
Employees
17
Employees17
Headquarters
Warren, New Jersey
HeadquartersWarren, New Jersey
Founded
2009
Founded2009
Employees
17
Employees17

BLPH Key Statistics

Market cap
824.45K
Market cap824.45K
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
286.89K
Average volume286.89K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$0.79
52 Week high$0.79
52 Week low
$0.27
52 Week low$0.27
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.